Having trouble accessing articles? Reset your cache.

Jennerex, Transgene in JX-594 deal

Jennerex Inc. (San Francisco, Calif.) granted Transgene S.A. (Euronext:TNG) exclusive rights to develop

Read the full 135 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE